Literature DB >> 34111956

Serous borderline ovarian tumours: an extensive review on MR imaging features.

Hilal Sahin1,2,3, Asli Irmak Akdogan4, Janette Smith5, Jeries Paolo Zawaideh5, Helen Addley2,5.   

Abstract

Serous borderline ovarian tumours (SBOTs) are an intermediate group of neoplasms, which have features between benign and malignant ovarian tumours and for which, fertility-sparing surgery can be offered. MRI in imaging of SBOTs is, therefore, crucial in raising the possibility of the diagnosis, in order to present the patient with the most appropriate treatment options. There are characteristic MRI features that SBOTs demonstrate. In addition, recent advanced techniques, and further classification into subtypes within the borderline group have been developed. The aim of this article is to review the MRI features of SBOT and provide the reporter with an awareness of the imaging tips and tricks in the differential diagnosis of SBOT.

Entities:  

Mesh:

Year:  2021        PMID: 34111956      PMCID: PMC9327754          DOI: 10.1259/bjr.20210116

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.629


  69 in total

1.  Magnetic resonance imaging radiomics in categorizing ovarian masses and predicting clinical outcome: a preliminary study.

Authors:  He Zhang; Yunfei Mao; Xiaojun Chen; Guoqing Wu; Xuefen Liu; Peng Zhang; Yu Bai; Pengcong Lu; Weigen Yao; Yuanyuan Wang; Jinhua Yu; Guofu Zhang
Journal:  Eur Radiol       Date:  2019-04-08       Impact factor: 5.315

2.  Ovarian serous surface papillary borderline tumors form sea anemone-like masses.

Authors:  Yumiko Oishi Tanaka; Satoshi Okada; Toyomi Satoh; Koji Matsumoto; Akinori Oki; Masato Nishida; Hiroyuki Yoshikawa; Tsukasa Saida; Manabu Minami
Journal:  J Magn Reson Imaging       Date:  2011-02-01       Impact factor: 4.813

3.  Ovarian serous surface papillary borderline tumor: characteristic imaging features with clinicopathological correlation.

Authors:  Sung Bin Park; Min-Jeong Kim; Kyoung Ho Lee; Yousun Ko
Journal:  Br J Radiol       Date:  2018-06-21       Impact factor: 3.039

Review 4.  Ultrasound of adnexal masses.

Authors:  Mukund Joshi; Karthik Ganesan; Harsha Navani Munshi; Subramania Ganesan; Ashwin Lawande
Journal:  Semin Ultrasound CT MR       Date:  2008-04       Impact factor: 1.875

5.  Role of proton MR spectroscopy in the differentiation of borderline from malignant epithelial ovarian tumors: A preliminary study.

Authors:  Feng Hua Ma; Yong Ai Li; Jia Liu; Hai Ming Li; Guo Fu Zhang; Jin Wei Qiang
Journal:  J Magn Reson Imaging       Date:  2018-10-24       Impact factor: 4.813

Review 6.  Pathology of borderline and invasive cancers.

Authors:  Jaime Prat
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2016-10-03       Impact factor: 5.237

7.  MRI appearances of ovarian serous borderline tumor: pathological correlation.

Authors:  Shu Hui Zhao; Jin Wei Qiang; Guo Fu Zhang; Orest B Boyko; Shi Jia Wang; Song Qi Cai; Li Wang
Journal:  J Magn Reson Imaging       Date:  2013-10-15       Impact factor: 4.813

Review 8.  Management of borderline ovarian tumours.

Authors:  David M Gershenson
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2016-10-03       Impact factor: 5.237

9.  Is MRI a useful tool to distinguish between serous and mucinous borderline ovarian tumours?

Authors:  M Bazot; D Haouy; E Daraï; A Cortez; S Dechoux-Vodovar; I Thomassin-Naggara
Journal:  Clin Radiol       Date:  2012-10-06       Impact factor: 2.350

10.  Four cases of endometrioid borderline ovarian tumour: case reports and literature review.

Authors:  Eriko Nakagawa; Kaoru Abiko; Aki Kido; Sachiko Kitamura; Ken Yamaguchi; Tsukasa Baba; Sachiko Minamiguchi; Noriomi Matsumura
Journal:  BJR Case Rep       Date:  2017-10-21
View more
  1 in total

1.  BJR female genitourinary oncology special feature: introductory editorial.

Authors:  Stephanie Nougaret; Hebert Alberto Vargas; Evis Sala
Journal:  Br J Radiol       Date:  2021-09-01       Impact factor: 3.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.